Pharmacological Adherence Behavior Changes during COVID-19 Outbreak in a Portugal Patient Cohort

Abstract

Concerns, behaviours, and beliefs influence how people deal with COVID-19. Understanding the factors influencing adherence behaviour is of utmost importance to develop tailored interventions to increase adherence within this context. Hence, we aimed to understand how COVID-19 affected adherence behaviour in Portugal. A cross-sectional online survey was conducted between 1 March and 3 April 2021. Descriptive statistics were performed, as well as univariable and multivariable regression models. Of the 1202 participants, 476 who were taking at least one medication prescribed by the doctor were selected. Of these, 78.2% were female, and the mean age was 40.3 ± 17.9 years old. About 74.2% were classified as being highly adherent. During the pandemic, 8.2% of participants reported that their adherence improved, while 5.9% had worsened adherence results. Compared with being single, widowers were 3 times more prone to be less adherent (OR:3.390 [1.106–10.390], p = 0.033). Comorbid patients were 1.8 times (OR:1.824 [1.155–2.881], p = 0.010) more prone to be less adherent. Participants who reported that COVID-19 negatively impacted their adherence were 5.6 times more prone to be less adherent, compared with those who reported no changes (OR:5.576 [2.420–12.847], p < 0.001). None of the other variables showed to be significantly associated with pharmacological adherence.

Out-of-pocket expenditure and catastrophic costs due to COVID-19 in Indonesia: A rapid online survey

“…This does not only prevent them from receiving complete examinations and treatments. This limitation is also deteriorating medication adherence among patients with chronic illness, particularly those with higher psychological stress resulting from the pandemic (9,10). Furthermore, many underinsured patients face a routine drug shortage.…”

Learning from the COVID-19 pandemic: health care disturbances and telemedicine as an alternative rheumatology practice in Indonesia

“…In contrast, a previous study showed no significant difference in adherence to medication between sexes during the pandemic. However, the study examined nonspecific diseases, while our study examined rheumatic autoimmune patients who were predominantly females [ 30 ].…”

Predicted Environmental Risk Assessment of Antimicrobials with Increased Consumption in Portugal during the COVID-19 Pandemic; The Groundwork for the Forthcoming Water Quality Survey

“…Behavioural interventions such as lockdowns, social distancing, and the usage of masks were then implemented, likely decreasing other infections and access to medical appointments. In addition, recommendations from the WHO narrowed antibiotics use [ 17 , 18 , 19 , 20 , 21 ]. These features are considered possible sources of the perceived significant negative growth rates of macrolides (e.g., azithromycin and clarithromycin) and quinolones (e.g., ciprofloxacin), mostly dispensed in ambulatory care.…”